zepbound and tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply access for adults living with obesity FDA approval for Zepbound (tirzepatide)

K.SarafS.SarafS.et al (2012)

The SAFA trial actively tracked side effects across 410 women on 50-100 mg/day

Farzanegi P, Dana A, Ebrahimpoor Z, Asadi M, Azarbayjani MA

In a statement before the lawsuit, the US Food and Drug Administration told CNN it had received reports of gastroparesis with semaglutide and liraglutide, some of which documented the adverse event as not recovered after discontinuation of the respective product at the time of the report. Ozempics prescribing information says the most common adverse events related to the drug are nausea, vomiting, diarrhea, abdominal pain and constipation

If dietary strategies are insufficient to address constipation, other therapies include daily magnesium supplementation, titrated to a dose to keep bowel movements regular

Looking for flavor without the added calories